ARTICLE | Clinical News
Binimetinib regulatory update
July 11, 2016 7:00 AM UTC
Array submitted an NDA to FDA for binimetinib to treat advanced neuroblastoma Ras viral (v-Ras) oncogene (NRAS) mutation-positive melanoma. Binimetinib is a small molecule selective MAP kinase kinas...